Arthneeti
CS

Clean Science

Q4 FY25Chemicals & Petrochemicals

Clean Science Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹822
Market cap₹8.8K Cr
P/E37.7
Updated26 Aug 2026
Read4 min read

The short version

Revenue potential is estimated between Rs. Revenue potential is expected to be Rs.

From Clean Science's Q4 FY25 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

  • Revenue potential is estimated between Rs. 2,500 crores to Rs. 3,000 crores, likely over the next three years.
  • Existing products are expected to grow at an industry rate of 5-6% annually.
  • New product launches, including performance chemicals and HALS, will drive significant growth and absorb overheads.
  • HALS sales target: from Rs. 80 crores in FY '25 to Rs. 210 crores in FY '26 and ramping up fully by FY '27-’28 with total capacity over 10,000 tons.
  • Performance chemicals (two new products) to commercialize in FY '26; revenue contribution expected mostly from FY '27 onward.
  • MEHQ volumes anticipated to grow 4%-5% year-on-year.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Clean Science said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY ’25 CAPEX: Rs. 215 crores invested in subsidiary Clean Fino-Chem.
  • FY ’26 CAPEX: Rs. 300 crores planned, primarily for two new performance chemical projects.
  • One product commercialization expected by August FY ’26.
  • Second product commercialization expected by February FY ’26.
  • Further CAPEX plans for FY ’27 will be announced around six months after these products come online.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem Ltd
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Clean Science said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly state the current or expected order book or pending orders for Clean Science and Technology Limited. However, some relevant points that indirectly reflect demand and growth expectations include: - HALS sales volume grew significantly from 600 tons in FY '24 to approximately 2,000 tons in FY '25. - Target for HALS sales in FY '26 is 4,500 tons, with full capacity expansion planned by FY '28 (total capacity: 10,000 tons). - Successful validation by key customers in Middle East, Southeast Asia, and Europe indicates strong sales momentum. - The company expects revenue potential of Rs. 2,500 to Rs. 3,000 crores in the next three years. - Margins are expected to be maintained around 40% EBITDA on a consolidated basis.

2 more points management made on order book & pipeline

Clean Science — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹249 Cr, net profit ₹58 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Clean Science's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Yasho Industries (Q4 FY25)

    Exports continue to be a key revenue driver, contributing around 67% of total revenue. Key concall takeaways from Yasho Industries's Q4 FY25 earnings call…

  • Vinati Organics Ltd (Q4 FY25)

    Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…

  • PCBL Chemical (Q4 FY25)

    Export sales volume for Carbon Black grew strongly by 16.8% in Q4 FY'25, reflecting strong international demand. Key concall takeaways from PCBL Chemical's Q4…

  • Fine Organic Industries Ltd (Q4 FY25)

    Domestic demand is growing strongly at around 8-10% CAGR, higher than the global average of 5-6%. Key concall takeaways from Fine Organic Industries Ltd's Q4…

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Clean Science Q4 FY25 results?

Revenue potential is estimated between Rs. Revenue potential is expected to be Rs.

What is Clean Science share price analysis?

Clean Science currently shows a neutral. The stock trades at a P/E of 37.7 with a market cap of ₹8,774 Cr. Investors should review the full earnings analysis for detailed insights.

Is Clean Science planning capital expenditure?

FY ’25 CAPEX: Rs.

Keep Clean Science on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.